Advances in motor neurone disease.

Advances in motor neurone disease.

Motor neurone disease (MND), the commonest clinical presentation of which is amyotrophic lateral sclerosis (ALS), is regarded as the most devastating of adult-onset neurodegenerative disorders. The last decade has seen major improvements in patient care, but also rapid scientific advances, so that r...

Bibliografske podrobnosti
Main Authors:	Bäumer, D, Talbot, K, Turner, M
Format:	Journal article
Jezik:	English
Izdano:	2014

Podobne knjige/članki

Mimics and chameleons in motor neurone disease.
od: Turner, M, et al.
Izdano: (2013)

Motor neurone disease is a clinical diagnosis.
od: Turner, M, et al.
Izdano: (2012)

The role of RNA processing in the pathogenesis of motor neuron degeneration.
od: Bäumer, D, et al.
Izdano: (2010)

The role of RNA processing in the pathogenesis of motor neuron degeneration
od: Bäumer, D, et al.
Izdano: (2010)

Functional genetic analysis of motor neuron disease
od: Bäumer, D
Izdano: (2010)

Motor neuron disease
od: Talbot, K
Izdano: (2009)

Motor neurone disease.
od: Talbot, K
Izdano: (2002)

Tracheostomy in motor neuron disease
od: Turner, M, et al.
Izdano: (2019)

An MRI biomarker for motor neuron disease?
od: Filippini, N, et al.
Izdano: (2010)

Motor neuron disease: the bare essentials.
od: Talbot, K
Izdano: (2009)

Advances in the clinical science of the motor unit: from motor neuron to neuromuscular junction.
od: Talbot, K, et al.
Izdano: (2014)

Treatable Mills syndrome: A unique case of coeliac disease mimicking motor neurone disease
od: Turner, M, et al.
Izdano: (2007)

Pre-symptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy.
od: Murray, L, et al.
Izdano: (2010)

Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice
od: Turner, B, et al.
Izdano: (2014)

Candidate screening of the bovine and feline spinal muscular atrophy genes reveals no evidence for involvement in human motor neuron disorders.
od: Parkinson, N, et al.
Izdano: (2008)

The treatment of motor neurone disease.
od: Turner, M
Izdano: (2001)

Nutritional pathway for people with motor neurone disease.
od: Marsden, R, et al.
Izdano: (2016)

The molecular genetics of non-ALS motor neuron diseases.
od: James, P, et al.
Izdano: (2006)

CORPUS CALLOSUM DIFFUSION TENSOR IMAGING AS A BIOMARKER FOR MOTOR NEURONE DISEASE
od: Filippini, N, et al.
Izdano: (2010)

Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice.
od: Turner, B, et al.
Izdano: (2014)

Public awareness of motor neuron disease.
od: Davies, Z, et al.
Izdano: (2010)

Is good housekeeping the key to motor neuron survival?
od: Talbot, K, et al.
Izdano: (2008)

Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model.
od: Turner, B, et al.
Izdano: (2009)

Motor neuron disease: biomarker development for an expanding cerebral syndrome
od: Turner, M
Izdano: (2016)

Neuroimaging in the Management of Motor Neuron Diseases
od: Filippi, M, et al.
Izdano: (2011)

Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy.
od: Murray, L, et al.
Izdano: (2010)

Spinal muscular atrophies reveal motor neuron vulnerability to defects in ribonucleoprotein handling.
od: Anderson, K, et al.
Izdano: (2003)

The impact of fatigue and psychosocial variables on quality of life for patients with motor neuron disease.
od: Gibbons, C, et al.
Izdano: (2013)

Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model
od: Bradley J. Turner, et al.
Izdano: (2009-06-01)

Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studies.
od: Fois, A, et al.
Izdano: (2010)

Communications Technology and Motor Neuron Disease: An Australian Survey of People With Motor Neuron Disease
od: Mackenzie, Lynette, et al.
Izdano: (2016-01-01)

Management of sialorrhoea in motor neuron disease: a survey of current UK practice.
od: Hobson, E, et al.
Izdano: (2013)

Neurotrophic Properties of C-Terminal Domain of the Heavy Chain of Tetanus Toxin on Motor Neuron Disease
od: Mireia Herrando-Grabulosa, et al.
Izdano: (2020-10-01)

EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases.
od: Filippi, M, et al.
Izdano: (2010)

Metabolic Dysfunction in Motor Neuron Disease: Shedding Light through the Lens of Autophagy
od: Subhavi De Silva, et al.
Izdano: (2022-06-01)

Neuroimaging of motor neuron diseases
od: Jan Kassubek, et al.
Izdano: (2012-03-01)

Rasch analysis of the hospital anxiety and depression scale (HADS) for use in motor neurone disease.
od: Gibbons, C, et al.
Izdano: (2011)

Assessing social isolation in motor neurone disease: A Rasch analysis of the MND Social Withdrawal Scale
od: Gibbons, C, et al.
Izdano: (2013)

Assessing social isolation in motor neurone disease: a Rasch analysis of the MND Social Withdrawal Scale.
od: Gibbons, C, et al.
Izdano: (2013)

Advances in Gene Delivery Methods to Label and Modulate Activity of Upper Motor Neurons: Implications for Amyotrophic Lateral Sclerosis
od: Mouna Haidar, et al.
Izdano: (2021-08-01)